Atopic Dermatitis Industry Overview 2025: Growth Projections and Market Trends

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Atopic Dermatitis Market Covering 2025–2034?

The atopic dermatitis market size has experienced rapid expansion over recent years. It is forecast to increase from $8.61 billion in 2024 to $9.88 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.7%. The historical period’s growth can be ascribed to improved medical understanding and awareness, incidence and prevalence rates, patient advocacy and support, the advancement of treatment options, and ongoing research and development.

The atopic dermatitis market size is anticipated to undergo significant growth over the next few years. Its value is expected to rise to $17.08 billion by 2029, with a compound annual growth rate (CAGR) of 14.7%. This expansion during the forecast period can be attributed to advancements in biologic therapies, the introduction of immunomodulators and small molecule drugs, specialized pediatric treatments, developments in gene therapy and precision medicine, and the incorporation of digital health. Major trends foreseen for this period include technological progress in topical applications, a heightened focus on pediatric AD care, improved environmental and allergen management, and the advent of precision diagnosis tools.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8285&type=smp

Which Factors And Drivers Are Influencing The Atopic Dermatitis Market In 2025?

The elevated prevalence of atopic dermatitis is projected to drive the growth of the atopic dermatitis market. Atopic dermatitis, also recognized as eczema, is a skin ailment causing dryness and itchiness. The increasing prevalence of this condition consequently escalates the necessity for its diagnosis and treatment. For example, according to Oxford Academic, a UK-based publishing company, atopic dermatitis (AD) is extensively prevalent worldwide, affecting approximately 2.6% of the world’s population, which amounts to about 204 million people in 2024. This count comprises around 101 million adults and 103 million children. Hence, the growing prevalence of atopic dermatitis is a primary driver for the expansion of the atopic dermatitis market.

What Are The Major Segments Identified In The Atopic Dermatitis Market?

The atopic dermatitismarket covered in this report is segmented –

1) By Drug Class: Corticosteroids; Emollients Or Moisturizers; IL-4 And PDE4 Inhibitors; Calcineurin Inhibitors; Antibiotics; Other Drug Classes

2) By Mode of Administration: Topical; Injectable; Oral

3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Subsegments:

1) By Corticosteroids: Topical Corticosteroids; Systemic Corticosteroids

2) By Emollients Or Moisturizers: Creams and Lotions; Ointments and Balms; Barrier Repair Creams

3) By IL-4 And PDE4 Inhibitors: Dupilumab (IL-4 Inhibitor); Apremilast (PDE4 Inhibitor)

4) By Calcineurin Inhibitors: Tacrolimus Ointment; Pimecrolimus Cream

5) By Antibiotics: Topical Antibiotics; Systemic Antibiotics

6) By Other Drug Classes: Antihistamines; Biologics; JAK Inhibitors

Which Trends Are Impacting The Atopic Dermatitis Market?

The atopic dermatitis market is experiencing product innovations as a prominent and increasingly popular trend. Major companies operating in this market are introducing advanced products to solidify their competitive positions. For example, in June 2022, the US-based biotechnology company, Regeneron Pharmaceuticals Inc., obtained FDA approval for Dupixent (dupilumab). Dupixent is indicated for children aged 6 months to 5 years who have moderate-to-severe atopic dermatitis. It can be used either with or without topical corticosteroids. Dupixent works by inhibiting the signaling of IL-4 and IL-13, two significant Type 2 inflammatory sources that are critical in the development of conditions such as eosinophilic esophagitis, prurigo nodularis, chronic rhinosinusitis with nasal polyposis, and asthma.

Which Major Industry Participants Are Leading The Atopic Dermatitis Market Growth?

Major companies operating in the atopic dermatitis market are Sanofi SA, Meda AB, Regeneron Pharmaceuticals Inc., Novartis International AG, Pfizer Inc., AbbVie Inc., Astellas Pharma Inc., Arcutis Biotherapeutics Inc., Asana Biosciences LLC, Dermavant Sciences Inc., Eli Lilly and Company, Galderma SA, Incyte Corporation, Bayer AG, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, F Hoffmann-La Roche AG, LEO Pharma A/S, Teva Pharmaceutical Industries Ltd., Mylan MV, Allergan PLC, Encore Dermatology Inc., Menlo Therapeutics Inc., Johnson & Johnson, Merck & Co Inc., Roche Holding AG, Valeant Pharmaceuticals International Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eisai Co. Ltd., Gilead Sciences Inc., Ipsen Biopharmaceuticals Inc., Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/atopic-dermatitis-global-market-report

What Are The Regional Market Dynamics Impacting The Atopic Dermatitis Industry?

North America was the largest region in the atopic dermatitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atopic dermatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Atopic Dermatitis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=8285&type=smp

Browse Through More Reports Similar to the Global Atopic Dermatitis Market 2025, By The Business Research Company

Dermatitis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Dermatology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

Dermatology Medical Lasers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-medical-lasers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795